首頁 > 市場調查報告書 > 工業機械

測量儀器生技設備

市場調查報告書

商品編碼

1148350

實驗室設備的全球市場:2022年～2027年

Lab Equipment Market - Forecasts from 2022 to 2027

出版日期: 2022年09月09日 | 出版商:

Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球實驗室設備的市場規模在2020年達到190億1,700萬美元的規模。

對新藥開發的研發投資增加以及藥物和疫苗開發技術的快速採用等因素正在推動市場的增長。癌症、糖尿病和哮喘等慢性病患病率上升預計也將推動未來幾年的增長。此外，對生物製品快速增長的需求也將推動未來五年的市場增長。

本報告提供全球實驗室設備的市場調查，彙整市場概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·各地區/主要國家的明細，競爭環境，主要企業簡介等資訊。

The lab equipment market was valued at US$19.017 billion in 2020. Lab equipment refers to all those tools and equipment that are used by scientists or workers working in a laboratory. Various types of equipment are used in these laboratories, which include mixers, furnaces, spectrometers, and conductivity meters among others. The primary factors that are significantly driving the market growth are the burgeoning adoption of technology for drug and vaccine development along with the rising investments in the R&D for the development of new drugs and medicines. Furthermore, the rising prevalence of chronic diseases such as cancer, diabetes, and asthma among others has led to rapid investments across the biopharmaceutical segment for the rapid advancement in technology and the development of new drugs to combat the growing number of diseases is also estimated to increase the potential of the lab equipment market to grow in the coming years. Moreover, there has been a rapid increase in the demand for biologics. biotics refers to a kind of drug produced by living organisms or containing components of living organisms. Biologics are becoming increasingly popular around the globe to cater to some of the most prevalent diseases, and are thus actively being researched, thus providing an impetus for the market to surge in the next five years. Also, according to the World Health Organization's International Clinical Registry Platform, out of all the trials in the pharmaceutical pipeline, spread across 50 different countries, in 2018, 40% of them were biologics. Thus, a significant rise in the demand for biologics is further projected to increase the R&D expenditure and thereby drive the market growth significantly.

Increasing investments by pharma companies in the R&D

The booming investments by pharmaceutical companies aiming to treat various chronic diseases expand the opportunities for the market to grow in the near future. Also, the rising initiatives by the governments of various countries have led to the formation of new schemes with an aim to accelerate the development of new innovative drugs, which is also considered a key factor expected to drive market growth. For instance, In November 2018, the French National Agency for the Safety of Medicines and Health Products announced new plans for further fast-track schemes in clinical trials for innovative gene and cell therapy drugs. The scheme is mainly focused on reducing the trial approval times by 25 or 30 days, thereby, enabling the companies to focus more on the development of new drugs.

Rising prevalence of chronic diseases

Chronic diseases are defined as conditions or symptoms that last a year or more than a year, along with the requirement for regular medical attention. The growing prevalence of chronic diseases in major countries is expected to augment the demand for new drugs. Chronic diseases include cancer, cardiac diseases, diabetes, stroke, cancer, chronic lung disease, Alzheimer's disease, and chronic kidney disease. However, heart disease, diabetes, and cancer are the major chronic diseases that are the leading causes of death and disability in the United States. Furthermore, a growing number of cancer cases will further boost the demand for efficient drugs during the forecast period. For instance, in the United States, more than 1.6 million people are diagnosed with cancer every year, and approximately around 6,00,000 deaths are caused by cancer, which makes cancer the second leading cause of death in the country (Source: U.S. Department of Health and Human Services). Moreover, approximately 30 million Americans suffer from diabetes, which further drives the demand for new and advanced drugs. As diabetes further increases the risk of heart disease, and kidney failure, the adoption of drug intake will further propel the demand during the next five years.

The lab equipment market has been segmented on the basis of type, end-user, and geography. By type, the market has been classified into with sample characteristic sensing and without sample characteristic sense. By the end-user, the classification has been done on the basis of government, biopharmaceutical, industrial, and others. Geographically, the segmentation has been done on the basis of North America, South America, Europe, the Middle East and Africa, and the Asia Pacific.

North America to hold a significant share

The North American market is projected to hold a noteworthy market share in 2019 owing to the presence of sophisticated healthcare infrastructure in countries such as the U.S.A. The presence of key biopharma companies in the region further bolsters market growth. The Asia Pacific region is anticipated to show robust growth opportunities during the coming years owing to the rising prevalence of chronic diseases and the growing investments in pharmaceutical research.

Competitive Insights

Prominent key market players in the lab equipment market include Eppendorf AG, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., and Thermo Fisher Scientific Inc. among others. These companies hold a noteworthy share of the market on account of their good brand image and product offerings.

Major players in the lab equipment market have been covered along with their relative competitive positions and strategies. The report also mentions recent deals and investments by different market players over the last two years.

Key Developments in the Market:

In February 2022, a global pioneer in mass photometry announced the launch of a new SamuxMP mass photometer, which significantly increases the time and cost-effectiveness of adeno-associated-virus (AAV) characterization. The SamuxMP, which was unveiled at PepTalk, addresses the shortcomings of the existing gold standard analytical techniques by enabling users to quickly and affordably calculate empty/full capsid ratios for AAVs of any serotype at the bench using very low sample concentrations and volumes as well as with minimal sample preparation.
In December 2021, a leading research and clinical diagnostics products provider, Bio-Rad Laboratories, Inc., launched the Bio-PlexTM Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays solely for research purposes. The assays enable researchers to rapidly and accurately assess neutralizing antibodies against the SARS-CoV-2 virus in its wild-type and major mutant forms.
In March 2022, Canada-based Life sciences brand, Nirvana Life sciences Inc, announced the acquisition of various lab equipment worth US$ 800,000, including modern distillation apparatus and two chromatography apparatuses, to advance the research progress in its Vancouver R&D campus.

COVID-19 Insights:

COVID-19 had a positive impact on the global lab equipment market. The rising investments in the research and development of innovative vaccines and the increasing prevalence of sample tests have further increased the demand for lab equipment in multiple nations. Furthermore, rising government funding for R&D for the development of vaccines and numerous medicines to meet the response to COVID is had significantly driven the lab equipment market in the coming years. For instance, in April 2020, the Department of Biotechnology, India announced that around 16 companies were granted funds to boost their R&D for the development of drugs and vaccines to speed up the process with the aim of tackling the disease.

Segmentation

By Type

With sample characteristic sensing

Without sample characteristic sensing

By End-User

Government

Biopharmaceutical

Industrial

Others

By Geography

North America

USA
Canada
Mexico

South America

Brazil
Argentina
Others

Europe

Germany
France
United Kingdom
Spain
Italy
Others

Middle East and Africa

Saudi Arabia
Israel
Others

Asia Pacific

China
Japan
South Korea
India
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Covid-19 Impact
1.3. Market Definition
1.4. Market Segmentation

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. LAB EQUIPMENT MARKET ANALYSIS, BY TYPE

5.1. Introduction
5.2. With sample characteristic sensing
5.3. Without sample characteristic sensing

6. LAB EQUIPMENT MARKET ANALYSIS, BY END-USER

6.1. Introduction
6.2. Government
6.3. Biopharmaceutical
6.4. Industrial
6.5. Others

7. LAB EQUIPMENT MARKET ANALYSIS, BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. North America Lab Equipment Market, By Type, 2020 to 2027
- 7.2.2. North America Lab Equipment Market, By End-User, 2020 to 2027
- 7.2.3. By Country
  - 7.2.3.1. USA
  - 7.2.3.2. Canada
  - 7.2.3.3. Mexico
7.3. South America
- 7.3.1. South America Lab Equipment Market, By Type, 2020 to 2027
- 7.3.2. South America Lab Equipment Market, By End-User, 2020 to 2027
- 7.3.3. By Country
  - 7.3.3.1. Brazil
  - 7.3.3.2. Argentina
  - 7.3.3.3. Others
7.4. Europe
- 7.4.1. Europe Lab Equipment Market, By Type, 2020 to 2027
- 7.4.2. Europe Lab Equipment Market, By End-User, 2020 to 2027
- 7.4.3. By Country
  - 7.4.3.1. Germany
  - 7.4.3.2. France
  - 7.4.3.3. United Kingdom
  - 7.4.3.4. Spain
  - 7.4.3.5. Italy
  - 7.4.3.6. Others
7.5. Middle East and Africa
- 7.5.1. Middle East and Africa Lab Equipment Market, By Type, 2020 to 2027
- 7.5.2. Middle East and Africa Lab Equipment Market, By End-User, 2020 to 2027
- 7.5.3. By Country
  - 7.5.3.1. Saudi Arabia
  - 7.5.3.2. Israel
  - 7.5.3.3. Others
7.6. Asia Pacific
- 7.6.1. Asia Pacific Lab Equipment Market, By Type, 2020 to 2027
- 7.6.2. Asia Pacific Lab Equipment Market, By End-User, 2020 to 2027
- 7.6.3. By Country
  - 7.6.3.1. China
  - 7.6.3.2. Japan
  - 7.6.3.3. South Korea
  - 7.6.3.4. India
  - 7.6.3.5. Indonesia
  - 7.6.3.6. Thailand
  - 7.6.3.7. Others